Literature DB >> 28637250

Use of SpyTag/SpyCatcher to construct bispecific antibodies that target two epitopes of a single antigen.

Kyohei Yumura1, Hiroki Akiba2, Satoru Nagatoishi2, Osamu Kusano-Arai3, Hiroko Iwanari3, Takao Hamakubo3, Kouhei Tsumoto1,2,4.   

Abstract

Bispecific antibody targeting of two different antigens is promising, but when fragment-based antibodies are used, homogeneous production is difficult. To overcome this difficulty, we developed a method using the SpyTag/SpyCatcher system in which a covalent bond is formed between the two polypeptides. Using this method, we constructed a bispecific antibody that simultaneously interacted with two different epitopes of roundabout homologue 1 (ROBO1), a membrane protein associated with cancer progression. A bispecific tetravalent antibody with an additional functional moiety was also constructed by using a dimeric biotin-binding protein. An interaction analysis of ROBO1-expressing cells and the recombinant antigen demonstrated the improved binding ability of the bispecific antibodies through spontaneous binding of the two antibody fragments to their respective epitopes. In addition, multivalency delayed dissociation, which is advantageous in therapy and diagnosis.
© The Authors 2017. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  SpyTag; biolayer interferometry; bispecific antibody; isothermal titration calorimetry; single-chain Fv

Mesh:

Substances:

Year:  2017        PMID: 28637250     DOI: 10.1093/jb/mvx023

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.

Authors:  Md Kausar Alam; Ayman El-Sayed; Kris Barreto; Wendy Bernhard; Humphrey Fonge; C Ronald Geyer
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

2.  Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Authors:  Mitchell S Weisenberger; Tara L Deans
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-19       Impact factor: 3.346

3.  Development of a bispecific immune engager using a recombinant malaria protein.

Authors:  Mie A Nordmaj; Morgan E Roberts; Emilie S Sachse; Robert Dagil; Anne Poder Andersen; Nanna Skeltved; Kaare V Grunddal; Sayit Mahmut Erdoğan; Swati Choudhary; Tobias Gustsavsson; Maj Sofie Ørum-Madsen; Igor Moskalev; Weihua Tian; Zhang Yang; Thomas M Clausen; Thor G Theander; Mads Daugaard; Morten A Nielsen; Ali Salanti
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

4.  Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing.

Authors:  Hiroki Akiba; Tomoko Ise; Satoshi Nagata; Haruhiko Kamada; Hiroaki Ohno; Kouhei Tsumoto
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

Review 5.  Chemical and Enzymatic Methods for Post-Translational Protein-Protein Conjugation.

Authors:  Ross J Taylor; Michael B Geeson; Toby Journeaux; Gonçalo J L Bernardes
Journal:  J Am Chem Soc       Date:  2022-07-31       Impact factor: 16.383

6.  A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.

Authors:  Md Kausar Alam; Michelle Brabant; Raja Solomon Viswas; Kris Barreto; Humphrey Fonge; C Ronald Geyer
Journal:  BMC Biotechnol       Date:  2018-09-10       Impact factor: 2.563

7.  Convergence in LINE-1 nucleotide variations can benefit redundantly forming triplexes with lncRNA in mammalian X-chromosome inactivation.

Authors:  Yoko Matsuno; Takefumi Yamashita; Michiru Wagatsuma; Hajime Yamakage
Journal:  Mob DNA       Date:  2019-07-30

Review 8.  Greatest Hits-Innovative Technologies for High Throughput Identification of Bispecific Antibodies.

Authors:  Tim Hofmann; Simon Krah; Carolin Sellmann; Stefan Zielonka; Achim Doerner
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.